nodes	percent_of_prediction	percent_of_DWPC	metapath
Guanabenz—Flatulence—Galantamine—Alzheimer's disease	0.00215	0.00255	CcSEcCtD
Guanabenz—Tension—Galantamine—Alzheimer's disease	0.00214	0.00254	CcSEcCtD
Guanabenz—Bronchospasm—Rivastigmine—Alzheimer's disease	0.00212	0.00252	CcSEcCtD
Guanabenz—Nervousness—Galantamine—Alzheimer's disease	0.00212	0.00252	CcSEcCtD
Guanabenz—Back pain—Galantamine—Alzheimer's disease	0.00211	0.00251	CcSEcCtD
Guanabenz—Muscle spasms—Galantamine—Alzheimer's disease	0.0021	0.00249	CcSEcCtD
Guanabenz—Vision blurred—Galantamine—Alzheimer's disease	0.00206	0.00244	CcSEcCtD
Guanabenz—Upper respiratory tract infection—Memantine—Alzheimer's disease	0.00205	0.00243	CcSEcCtD
Guanabenz—Ill-defined disorder—Galantamine—Alzheimer's disease	0.00203	0.00241	CcSEcCtD
Guanabenz—Anaemia—Galantamine—Alzheimer's disease	0.00202	0.0024	CcSEcCtD
Guanabenz—Weight increased—Memantine—Alzheimer's disease	0.00201	0.00238	CcSEcCtD
Guanabenz—Agitation—Galantamine—Alzheimer's disease	0.00201	0.00238	CcSEcCtD
Guanabenz—Upper respiratory tract infection—Rivastigmine—Alzheimer's disease	0.00201	0.00238	CcSEcCtD
Guanabenz—Weight decreased—Memantine—Alzheimer's disease	0.002	0.00237	CcSEcCtD
Guanabenz—Hyperglycaemia—Memantine—Alzheimer's disease	0.00199	0.00236	CcSEcCtD
Guanabenz—Malaise—Galantamine—Alzheimer's disease	0.00197	0.00234	CcSEcCtD
Guanabenz—Infestation NOS—Memantine—Alzheimer's disease	0.00197	0.00233	CcSEcCtD
Guanabenz—Infestation—Memantine—Alzheimer's disease	0.00197	0.00233	CcSEcCtD
Guanabenz—Weight increased—Rivastigmine—Alzheimer's disease	0.00196	0.00233	CcSEcCtD
Guanabenz—Syncope—Galantamine—Alzheimer's disease	0.00196	0.00232	CcSEcCtD
Guanabenz—Haemoglobin—Donepezil—Alzheimer's disease	0.00196	0.00232	CcSEcCtD
Guanabenz—Weight decreased—Rivastigmine—Alzheimer's disease	0.00195	0.00232	CcSEcCtD
Guanabenz—Hyperglycaemia—Rivastigmine—Alzheimer's disease	0.00195	0.00231	CcSEcCtD
Guanabenz—Haemorrhage—Donepezil—Alzheimer's disease	0.00195	0.00231	CcSEcCtD
Guanabenz—Infestation NOS—Rivastigmine—Alzheimer's disease	0.00193	0.00228	CcSEcCtD
Guanabenz—Infestation—Rivastigmine—Alzheimer's disease	0.00193	0.00228	CcSEcCtD
Guanabenz—Loss of consciousness—Galantamine—Alzheimer's disease	0.00192	0.00228	CcSEcCtD
Guanabenz—Oedema peripheral—Donepezil—Alzheimer's disease	0.00192	0.00227	CcSEcCtD
Guanabenz—Cough—Galantamine—Alzheimer's disease	0.00191	0.00226	CcSEcCtD
Guanabenz—Hypertension—Galantamine—Alzheimer's disease	0.00189	0.00224	CcSEcCtD
Guanabenz—Chest pain—Galantamine—Alzheimer's disease	0.00186	0.00221	CcSEcCtD
Guanabenz—Myalgia—Galantamine—Alzheimer's disease	0.00186	0.00221	CcSEcCtD
Guanabenz—Arthralgia—Galantamine—Alzheimer's disease	0.00186	0.00221	CcSEcCtD
Guanabenz—Anxiety—Galantamine—Alzheimer's disease	0.00185	0.0022	CcSEcCtD
Guanabenz—Discomfort—Galantamine—Alzheimer's disease	0.00184	0.00218	CcSEcCtD
Guanabenz—Dry mouth—Galantamine—Alzheimer's disease	0.00182	0.00216	CcSEcCtD
Guanabenz—Tinnitus—Donepezil—Alzheimer's disease	0.00181	0.00215	CcSEcCtD
Guanabenz—Confusional state—Galantamine—Alzheimer's disease	0.0018	0.00213	CcSEcCtD
Guanabenz—Haemoglobin—Memantine—Alzheimer's disease	0.00178	0.00211	CcSEcCtD
Guanabenz—Haemorrhage—Memantine—Alzheimer's disease	0.00177	0.0021	CcSEcCtD
Guanabenz—Shock—Galantamine—Alzheimer's disease	0.00175	0.00208	CcSEcCtD
Guanabenz—Nervous system disorder—Galantamine—Alzheimer's disease	0.00175	0.00207	CcSEcCtD
Guanabenz—Thrombocytopenia—Galantamine—Alzheimer's disease	0.00175	0.00207	CcSEcCtD
Guanabenz—Chills—Donepezil—Alzheimer's disease	0.00175	0.00207	CcSEcCtD
Guanabenz—Tachycardia—Galantamine—Alzheimer's disease	0.00174	0.00207	CcSEcCtD
Guanabenz—Oedema peripheral—Memantine—Alzheimer's disease	0.00174	0.00206	CcSEcCtD
Guanabenz—Haemoglobin—Rivastigmine—Alzheimer's disease	0.00174	0.00206	CcSEcCtD
Guanabenz—Connective tissue disorder—Memantine—Alzheimer's disease	0.00174	0.00206	CcSEcCtD
Guanabenz—Skin disorder—Galantamine—Alzheimer's disease	0.00173	0.00206	CcSEcCtD
Guanabenz—Haemorrhage—Rivastigmine—Alzheimer's disease	0.00173	0.00205	CcSEcCtD
Guanabenz—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.0017	0.00202	CcSEcCtD
Guanabenz—Anorexia—Galantamine—Alzheimer's disease	0.0017	0.00202	CcSEcCtD
Guanabenz—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.0017	0.00201	CcSEcCtD
Guanabenz—Erythema—Donepezil—Alzheimer's disease	0.00169	0.00201	CcSEcCtD
Guanabenz—Malnutrition—Donepezil—Alzheimer's disease	0.00169	0.00201	CcSEcCtD
Guanabenz—Erythema multiforme—Memantine—Alzheimer's disease	0.00167	0.00198	CcSEcCtD
Guanabenz—Flatulence—Donepezil—Alzheimer's disease	0.00167	0.00198	CcSEcCtD
Guanabenz—Hypotension—Galantamine—Alzheimer's disease	0.00167	0.00198	CcSEcCtD
Guanabenz—Tension—Donepezil—Alzheimer's disease	0.00166	0.00197	CcSEcCtD
Guanabenz—Eye disorder—Memantine—Alzheimer's disease	0.00165	0.00196	CcSEcCtD
Guanabenz—Tinnitus—Memantine—Alzheimer's disease	0.00165	0.00195	CcSEcCtD
Guanabenz—Nervousness—Donepezil—Alzheimer's disease	0.00165	0.00195	CcSEcCtD
Guanabenz—Back pain—Donepezil—Alzheimer's disease	0.00164	0.00194	CcSEcCtD
Guanabenz—Erythema multiforme—Rivastigmine—Alzheimer's disease	0.00163	0.00194	CcSEcCtD
Guanabenz—Muscle spasms—Donepezil—Alzheimer's disease	0.00163	0.00193	CcSEcCtD
Guanabenz—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.00163	0.00193	CcSEcCtD
Guanabenz—Eye disorder—Rivastigmine—Alzheimer's disease	0.00162	0.00192	CcSEcCtD
Guanabenz—Tinnitus—Rivastigmine—Alzheimer's disease	0.00161	0.00191	CcSEcCtD
Guanabenz—Paraesthesia—Galantamine—Alzheimer's disease	0.0016	0.0019	CcSEcCtD
Guanabenz—Vision blurred—Donepezil—Alzheimer's disease	0.0016	0.00189	CcSEcCtD
Guanabenz—Immune system disorder—Memantine—Alzheimer's disease	0.0016	0.00189	CcSEcCtD
Guanabenz—Mediastinal disorder—Memantine—Alzheimer's disease	0.00159	0.00189	CcSEcCtD
Guanabenz—Chills—Memantine—Alzheimer's disease	0.00159	0.00188	CcSEcCtD
Guanabenz—Ill-defined disorder—Donepezil—Alzheimer's disease	0.00157	0.00186	CcSEcCtD
Guanabenz—Dyspepsia—Galantamine—Alzheimer's disease	0.00157	0.00186	CcSEcCtD
Guanabenz—Anaemia—Donepezil—Alzheimer's disease	0.00157	0.00186	CcSEcCtD
Guanabenz—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.00156	0.00185	CcSEcCtD
Guanabenz—Agitation—Donepezil—Alzheimer's disease	0.00156	0.00185	CcSEcCtD
Guanabenz—Chills—Rivastigmine—Alzheimer's disease	0.00155	0.00184	CcSEcCtD
Guanabenz—Decreased appetite—Galantamine—Alzheimer's disease	0.00155	0.00184	CcSEcCtD
Guanabenz—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.00154	0.00183	CcSEcCtD
Guanabenz—Malnutrition—Memantine—Alzheimer's disease	0.00154	0.00182	CcSEcCtD
Guanabenz—Fatigue—Galantamine—Alzheimer's disease	0.00154	0.00182	CcSEcCtD
Guanabenz—Malaise—Donepezil—Alzheimer's disease	0.00153	0.00181	CcSEcCtD
Guanabenz—Constipation—Galantamine—Alzheimer's disease	0.00153	0.00181	CcSEcCtD
Guanabenz—Syncope—Donepezil—Alzheimer's disease	0.00152	0.0018	CcSEcCtD
Guanabenz—Flatulence—Memantine—Alzheimer's disease	0.00152	0.0018	CcSEcCtD
Guanabenz—Tension—Memantine—Alzheimer's disease	0.00151	0.00179	CcSEcCtD
Guanabenz—Malnutrition—Rivastigmine—Alzheimer's disease	0.0015	0.00178	CcSEcCtD
Guanabenz—Erythema—Rivastigmine—Alzheimer's disease	0.0015	0.00178	CcSEcCtD
Guanabenz—Nervousness—Memantine—Alzheimer's disease	0.00149	0.00177	CcSEcCtD
Guanabenz—Loss of consciousness—Donepezil—Alzheimer's disease	0.00149	0.00177	CcSEcCtD
Guanabenz—Back pain—Memantine—Alzheimer's disease	0.00149	0.00176	CcSEcCtD
Guanabenz—Flatulence—Rivastigmine—Alzheimer's disease	0.00148	0.00176	CcSEcCtD
Guanabenz—Cough—Donepezil—Alzheimer's disease	0.00148	0.00175	CcSEcCtD
Guanabenz—Tension—Rivastigmine—Alzheimer's disease	0.00148	0.00175	CcSEcCtD
Guanabenz—Feeling abnormal—Galantamine—Alzheimer's disease	0.00147	0.00174	CcSEcCtD
Guanabenz—Hypertension—Donepezil—Alzheimer's disease	0.00146	0.00173	CcSEcCtD
Guanabenz—Nervousness—Rivastigmine—Alzheimer's disease	0.00146	0.00173	CcSEcCtD
Guanabenz—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.00146	0.00173	CcSEcCtD
Guanabenz—Back pain—Rivastigmine—Alzheimer's disease	0.00146	0.00173	CcSEcCtD
Guanabenz—Vision blurred—Memantine—Alzheimer's disease	0.00145	0.00172	CcSEcCtD
Guanabenz—Muscle spasms—Rivastigmine—Alzheimer's disease	0.00145	0.00172	CcSEcCtD
Guanabenz—Chest pain—Donepezil—Alzheimer's disease	0.00144	0.00171	CcSEcCtD
Guanabenz—Myalgia—Donepezil—Alzheimer's disease	0.00144	0.00171	CcSEcCtD
Guanabenz—Arthralgia—Donepezil—Alzheimer's disease	0.00144	0.00171	CcSEcCtD
Guanabenz—Anxiety—Donepezil—Alzheimer's disease	0.00144	0.0017	CcSEcCtD
Guanabenz—Ill-defined disorder—Memantine—Alzheimer's disease	0.00143	0.00169	CcSEcCtD
Guanabenz—Discomfort—Donepezil—Alzheimer's disease	0.00142	0.00169	CcSEcCtD
Guanabenz—Anaemia—Memantine—Alzheimer's disease	0.00142	0.00169	CcSEcCtD
Guanabenz—Vision blurred—Rivastigmine—Alzheimer's disease	0.00142	0.00168	CcSEcCtD
Guanabenz—Agitation—Memantine—Alzheimer's disease	0.00141	0.00168	CcSEcCtD
Guanabenz—Dry mouth—Donepezil—Alzheimer's disease	0.00141	0.00167	CcSEcCtD
Guanabenz—Abdominal pain—Galantamine—Alzheimer's disease	0.00141	0.00167	CcSEcCtD
Guanabenz—Body temperature increased—Galantamine—Alzheimer's disease	0.00141	0.00167	CcSEcCtD
Guanabenz—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.0014	0.00166	CcSEcCtD
Guanabenz—Confusional state—Donepezil—Alzheimer's disease	0.00139	0.00165	CcSEcCtD
Guanabenz—Anaemia—Rivastigmine—Alzheimer's disease	0.00139	0.00165	CcSEcCtD
Guanabenz—Malaise—Memantine—Alzheimer's disease	0.00139	0.00165	CcSEcCtD
Guanabenz—Agitation—Rivastigmine—Alzheimer's disease	0.00138	0.00164	CcSEcCtD
Guanabenz—Oedema—Donepezil—Alzheimer's disease	0.00138	0.00164	CcSEcCtD
Guanabenz—Syncope—Memantine—Alzheimer's disease	0.00138	0.00164	CcSEcCtD
Guanabenz—Leukopenia—Memantine—Alzheimer's disease	0.00138	0.00163	CcSEcCtD
Guanabenz—Infection—Donepezil—Alzheimer's disease	0.00137	0.00163	CcSEcCtD
Guanabenz—Shock—Donepezil—Alzheimer's disease	0.00136	0.00161	CcSEcCtD
Guanabenz—Malaise—Rivastigmine—Alzheimer's disease	0.00136	0.00161	CcSEcCtD
Guanabenz—Nervous system disorder—Donepezil—Alzheimer's disease	0.00136	0.00161	CcSEcCtD
Guanabenz—Thrombocytopenia—Donepezil—Alzheimer's disease	0.00135	0.00161	CcSEcCtD
Guanabenz—Loss of consciousness—Memantine—Alzheimer's disease	0.00135	0.0016	CcSEcCtD
Guanabenz—Syncope—Rivastigmine—Alzheimer's disease	0.00135	0.0016	CcSEcCtD
Guanabenz—Cough—Memantine—Alzheimer's disease	0.00134	0.00159	CcSEcCtD
Guanabenz—Hypertension—Memantine—Alzheimer's disease	0.00133	0.00158	CcSEcCtD
Guanabenz—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.00132	0.00157	CcSEcCtD
Guanabenz—Anorexia—Donepezil—Alzheimer's disease	0.00132	0.00156	CcSEcCtD
Guanabenz—Hypersensitivity—Galantamine—Alzheimer's disease	0.00131	0.00156	CcSEcCtD
Guanabenz—Cough—Rivastigmine—Alzheimer's disease	0.00131	0.00156	CcSEcCtD
Guanabenz—Chest pain—Memantine—Alzheimer's disease	0.00131	0.00155	CcSEcCtD
Guanabenz—Myalgia—Memantine—Alzheimer's disease	0.00131	0.00155	CcSEcCtD
Guanabenz—Arthralgia—Memantine—Alzheimer's disease	0.00131	0.00155	CcSEcCtD
Guanabenz—Anxiety—Memantine—Alzheimer's disease	0.0013	0.00155	CcSEcCtD
Guanabenz—Hypertension—Rivastigmine—Alzheimer's disease	0.0013	0.00154	CcSEcCtD
Guanabenz—Discomfort—Memantine—Alzheimer's disease	0.00129	0.00153	CcSEcCtD
Guanabenz—Hypotension—Donepezil—Alzheimer's disease	0.00129	0.00153	CcSEcCtD
Guanabenz—Chest pain—Rivastigmine—Alzheimer's disease	0.00128	0.00152	CcSEcCtD
Guanabenz—Arthralgia—Rivastigmine—Alzheimer's disease	0.00128	0.00152	CcSEcCtD
Guanabenz—Myalgia—Rivastigmine—Alzheimer's disease	0.00128	0.00152	CcSEcCtD
Guanabenz—Dry mouth—Memantine—Alzheimer's disease	0.00128	0.00152	CcSEcCtD
Guanabenz—Asthenia—Galantamine—Alzheimer's disease	0.00128	0.00152	CcSEcCtD
Guanabenz—Anxiety—Rivastigmine—Alzheimer's disease	0.00128	0.00151	CcSEcCtD
Guanabenz—Confusional state—Memantine—Alzheimer's disease	0.00127	0.0015	CcSEcCtD
Guanabenz—Discomfort—Rivastigmine—Alzheimer's disease	0.00127	0.0015	CcSEcCtD
Guanabenz—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.00126	0.00149	CcSEcCtD
Guanabenz—Oedema—Memantine—Alzheimer's disease	0.00126	0.00149	CcSEcCtD
Guanabenz—Dry mouth—Rivastigmine—Alzheimer's disease	0.00125	0.00149	CcSEcCtD
Guanabenz—Infection—Memantine—Alzheimer's disease	0.00125	0.00148	CcSEcCtD
Guanabenz—Paraesthesia—Donepezil—Alzheimer's disease	0.00124	0.00147	CcSEcCtD
Guanabenz—Confusional state—Rivastigmine—Alzheimer's disease	0.00124	0.00147	CcSEcCtD
Guanabenz—Shock—Memantine—Alzheimer's disease	0.00123	0.00146	CcSEcCtD
Guanabenz—Dyspnoea—Donepezil—Alzheimer's disease	0.00123	0.00146	CcSEcCtD
Guanabenz—Nervous system disorder—Memantine—Alzheimer's disease	0.00123	0.00146	CcSEcCtD
Guanabenz—Thrombocytopenia—Memantine—Alzheimer's disease	0.00123	0.00146	CcSEcCtD
Guanabenz—Oedema—Rivastigmine—Alzheimer's disease	0.00123	0.00146	CcSEcCtD
Guanabenz—Tachycardia—Memantine—Alzheimer's disease	0.00122	0.00145	CcSEcCtD
Guanabenz—Diarrhoea—Galantamine—Alzheimer's disease	0.00122	0.00145	CcSEcCtD
Guanabenz—Infection—Rivastigmine—Alzheimer's disease	0.00122	0.00145	CcSEcCtD
Guanabenz—Skin disorder—Memantine—Alzheimer's disease	0.00122	0.00145	CcSEcCtD
Guanabenz—Dyspepsia—Donepezil—Alzheimer's disease	0.00122	0.00144	CcSEcCtD
Guanabenz—Shock—Rivastigmine—Alzheimer's disease	0.00121	0.00143	CcSEcCtD
Guanabenz—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.0012	0.00143	CcSEcCtD
Guanabenz—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.0012	0.00143	CcSEcCtD
Guanabenz—Decreased appetite—Donepezil—Alzheimer's disease	0.0012	0.00143	CcSEcCtD
Guanabenz—Tachycardia—Rivastigmine—Alzheimer's disease	0.0012	0.00142	CcSEcCtD
Guanabenz—Anorexia—Memantine—Alzheimer's disease	0.0012	0.00142	CcSEcCtD
Guanabenz—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.00119	0.00142	CcSEcCtD
Guanabenz—Skin disorder—Rivastigmine—Alzheimer's disease	0.00119	0.00141	CcSEcCtD
Guanabenz—Fatigue—Donepezil—Alzheimer's disease	0.00119	0.00141	CcSEcCtD
Guanabenz—Constipation—Donepezil—Alzheimer's disease	0.00118	0.0014	CcSEcCtD
Guanabenz—Pain—Donepezil—Alzheimer's disease	0.00118	0.0014	CcSEcCtD
Guanabenz—Dizziness—Galantamine—Alzheimer's disease	0.00118	0.0014	CcSEcCtD
Guanabenz—Hypotension—Memantine—Alzheimer's disease	0.00117	0.00139	CcSEcCtD
Guanabenz—Anorexia—Rivastigmine—Alzheimer's disease	0.00117	0.00139	CcSEcCtD
Guanabenz—Hypotension—Rivastigmine—Alzheimer's disease	0.00115	0.00136	CcSEcCtD
Guanabenz—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.00114	0.00136	CcSEcCtD
Guanabenz—Feeling abnormal—Donepezil—Alzheimer's disease	0.00114	0.00135	CcSEcCtD
Guanabenz—Vomiting—Galantamine—Alzheimer's disease	0.00113	0.00135	CcSEcCtD
Guanabenz—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.00113	0.00134	CcSEcCtD
Guanabenz—Paraesthesia—Memantine—Alzheimer's disease	0.00113	0.00134	CcSEcCtD
Guanabenz—Rash—Galantamine—Alzheimer's disease	0.00112	0.00133	CcSEcCtD
Guanabenz—Dermatitis—Galantamine—Alzheimer's disease	0.00112	0.00133	CcSEcCtD
Guanabenz—Dyspnoea—Memantine—Alzheimer's disease	0.00112	0.00133	CcSEcCtD
Guanabenz—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.00112	0.00133	CcSEcCtD
Guanabenz—Headache—Galantamine—Alzheimer's disease	0.00112	0.00133	CcSEcCtD
Guanabenz—Dyspepsia—Memantine—Alzheimer's disease	0.0011	0.00131	CcSEcCtD
Guanabenz—Paraesthesia—Rivastigmine—Alzheimer's disease	0.0011	0.00131	CcSEcCtD
Guanabenz—Urticaria—Donepezil—Alzheimer's disease	0.0011	0.0013	CcSEcCtD
Guanabenz—Dyspnoea—Rivastigmine—Alzheimer's disease	0.00109	0.0013	CcSEcCtD
Guanabenz—Abdominal pain—Donepezil—Alzheimer's disease	0.00109	0.0013	CcSEcCtD
Guanabenz—Body temperature increased—Donepezil—Alzheimer's disease	0.00109	0.0013	CcSEcCtD
Guanabenz—Decreased appetite—Memantine—Alzheimer's disease	0.00109	0.00129	CcSEcCtD
Guanabenz—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.00108	0.00129	CcSEcCtD
Guanabenz—Fatigue—Memantine—Alzheimer's disease	0.00108	0.00128	CcSEcCtD
Guanabenz—Dyspepsia—Rivastigmine—Alzheimer's disease	0.00108	0.00128	CcSEcCtD
Guanabenz—Pain—Memantine—Alzheimer's disease	0.00107	0.00127	CcSEcCtD
Guanabenz—Constipation—Memantine—Alzheimer's disease	0.00107	0.00127	CcSEcCtD
Guanabenz—Decreased appetite—Rivastigmine—Alzheimer's disease	0.00107	0.00127	CcSEcCtD
Guanabenz—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.00106	0.00126	CcSEcCtD
Guanabenz—Nausea—Galantamine—Alzheimer's disease	0.00106	0.00126	CcSEcCtD
Guanabenz—Fatigue—Rivastigmine—Alzheimer's disease	0.00106	0.00126	CcSEcCtD
Guanabenz—Pain—Rivastigmine—Alzheimer's disease	0.00105	0.00125	CcSEcCtD
Guanabenz—Constipation—Rivastigmine—Alzheimer's disease	0.00105	0.00125	CcSEcCtD
Guanabenz—Feeling abnormal—Memantine—Alzheimer's disease	0.00103	0.00123	CcSEcCtD
Guanabenz—Gastrointestinal pain—Memantine—Alzheimer's disease	0.00103	0.00122	CcSEcCtD
Guanabenz—Hypersensitivity—Donepezil—Alzheimer's disease	0.00102	0.00121	CcSEcCtD
Guanabenz—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.00101	0.0012	CcSEcCtD
Guanabenz—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.001	0.00119	CcSEcCtD
Guanabenz—Urticaria—Memantine—Alzheimer's disease	0.000997	0.00118	CcSEcCtD
Guanabenz—Abdominal pain—Memantine—Alzheimer's disease	0.000992	0.00118	CcSEcCtD
Guanabenz—Body temperature increased—Memantine—Alzheimer's disease	0.000992	0.00118	CcSEcCtD
Guanabenz—Asthenia—Donepezil—Alzheimer's disease	0.000992	0.00118	CcSEcCtD
Guanabenz—Pruritus—Donepezil—Alzheimer's disease	0.000978	0.00116	CcSEcCtD
Guanabenz—Urticaria—Rivastigmine—Alzheimer's disease	0.000975	0.00116	CcSEcCtD
Guanabenz—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000971	0.00115	CcSEcCtD
Guanabenz—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000971	0.00115	CcSEcCtD
Guanabenz—Diarrhoea—Donepezil—Alzheimer's disease	0.000946	0.00112	CcSEcCtD
Guanabenz—Hypersensitivity—Memantine—Alzheimer's disease	0.000925	0.0011	CcSEcCtD
Guanabenz—Dizziness—Donepezil—Alzheimer's disease	0.000914	0.00108	CcSEcCtD
Guanabenz—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000905	0.00107	CcSEcCtD
Guanabenz—Asthenia—Memantine—Alzheimer's disease	0.000901	0.00107	CcSEcCtD
Guanabenz—Pruritus—Memantine—Alzheimer's disease	0.000888	0.00105	CcSEcCtD
Guanabenz—Asthenia—Rivastigmine—Alzheimer's disease	0.000881	0.00105	CcSEcCtD
Guanabenz—Vomiting—Donepezil—Alzheimer's disease	0.000879	0.00104	CcSEcCtD
Guanabenz—Rash—Donepezil—Alzheimer's disease	0.000872	0.00103	CcSEcCtD
Guanabenz—Dermatitis—Donepezil—Alzheimer's disease	0.000871	0.00103	CcSEcCtD
Guanabenz—Pruritus—Rivastigmine—Alzheimer's disease	0.000869	0.00103	CcSEcCtD
Guanabenz—Headache—Donepezil—Alzheimer's disease	0.000866	0.00103	CcSEcCtD
Guanabenz—Diarrhoea—Memantine—Alzheimer's disease	0.000859	0.00102	CcSEcCtD
Guanabenz—Diarrhoea—Rivastigmine—Alzheimer's disease	0.00084	0.000997	CcSEcCtD
Guanabenz—Dizziness—Memantine—Alzheimer's disease	0.00083	0.000985	CcSEcCtD
Guanabenz—Nausea—Donepezil—Alzheimer's disease	0.000821	0.000974	CcSEcCtD
Guanabenz—Dizziness—Rivastigmine—Alzheimer's disease	0.000812	0.000963	CcSEcCtD
Guanabenz—Vomiting—Memantine—Alzheimer's disease	0.000798	0.000947	CcSEcCtD
Guanabenz—Rash—Memantine—Alzheimer's disease	0.000791	0.000939	CcSEcCtD
Guanabenz—Dermatitis—Memantine—Alzheimer's disease	0.000791	0.000938	CcSEcCtD
Guanabenz—Headache—Memantine—Alzheimer's disease	0.000786	0.000933	CcSEcCtD
Guanabenz—Vomiting—Rivastigmine—Alzheimer's disease	0.000781	0.000926	CcSEcCtD
Guanabenz—Rash—Rivastigmine—Alzheimer's disease	0.000774	0.000918	CcSEcCtD
Guanabenz—Dermatitis—Rivastigmine—Alzheimer's disease	0.000773	0.000918	CcSEcCtD
Guanabenz—Headache—Rivastigmine—Alzheimer's disease	0.000769	0.000912	CcSEcCtD
Guanabenz—Nausea—Memantine—Alzheimer's disease	0.000746	0.000884	CcSEcCtD
Guanabenz—Nausea—Rivastigmine—Alzheimer's disease	0.000729	0.000865	CcSEcCtD
Guanabenz—ADRA2A—Signaling Pathways—GFAP—Alzheimer's disease	7.13e-05	0.000454	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—CRH—Alzheimer's disease	7.12e-05	0.000454	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR downstream signaling—HTR2A—Alzheimer's disease	7.07e-05	0.00045	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	7.06e-05	0.00045	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—CCR5—Alzheimer's disease	7.02e-05	0.000447	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—BCHE—Alzheimer's disease	7.01e-05	0.000447	CbGpPWpGaD
Guanabenz—ADRA2A—Hemostasis—IGF1—Alzheimer's disease	6.98e-05	0.000445	CbGpPWpGaD
Guanabenz—ADRA2C—Platelet activation, signaling and aggregation—AKT1—Alzheimer's disease	6.95e-05	0.000443	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—PRKCG—Alzheimer's disease	6.92e-05	0.000441	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—NPY—Alzheimer's disease	6.89e-05	0.000439	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—HTR2A—Alzheimer's disease	6.87e-05	0.000438	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—IAPP—Alzheimer's disease	6.85e-05	0.000436	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—NPS—Alzheimer's disease	6.75e-05	0.00043	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—PPP3CA—Alzheimer's disease	6.72e-05	0.000428	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—CRH—Alzheimer's disease	6.65e-05	0.000424	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR downstream signaling—F2—Alzheimer's disease	6.64e-05	0.000423	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—PTK2B—Alzheimer's disease	6.62e-05	0.000422	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—PLCB1—Alzheimer's disease	6.61e-05	0.000421	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—CCR5—Alzheimer's disease	6.56e-05	0.000418	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—ACHE—Alzheimer's disease	6.54e-05	0.000416	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—INPP5D—Alzheimer's disease	6.46e-05	0.000412	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	6.46e-05	0.000411	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—SST—Alzheimer's disease	6.44e-05	0.00041	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—GAB2—Alzheimer's disease	6.44e-05	0.00041	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—NTRK2—Alzheimer's disease	6.44e-05	0.00041	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—HTR2A—Alzheimer's disease	6.42e-05	0.000409	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—CALM1—Alzheimer's disease	6.41e-05	0.000408	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—ABCA1—Alzheimer's disease	6.41e-05	0.000408	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—GSK3A—Alzheimer's disease	6.38e-05	0.000407	CbGpPWpGaD
Guanabenz—ADRA2A—Hemostasis—NOS3—Alzheimer's disease	6.33e-05	0.000403	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—NPS—Alzheimer's disease	6.31e-05	0.000402	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—A2M—Alzheimer's disease	6.28e-05	0.0004	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—APP—Alzheimer's disease	6.28e-05	0.0004	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—PPP3CA—Alzheimer's disease	6.27e-05	0.0004	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR downstream signaling—F2—Alzheimer's disease	6.2e-05	0.000395	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—PRKCG—Alzheimer's disease	6.19e-05	0.000394	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—PTK2B—Alzheimer's disease	6.18e-05	0.000394	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—ENO1—Alzheimer's disease	6.12e-05	0.00039	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—PTGS1—Alzheimer's disease	6.12e-05	0.00039	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PSEN2—Alzheimer's disease	6.08e-05	0.000388	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—F2—Alzheimer's disease	6.03e-05	0.000384	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—GAB2—Alzheimer's disease	6.02e-05	0.000383	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—NTRK2—Alzheimer's disease	6.02e-05	0.000383	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—SST—Alzheimer's disease	6.02e-05	0.000383	CbGpPWpGaD
Guanabenz—ADRA2B—Hemostasis—VEGFA—Alzheimer's disease	6.01e-05	0.000383	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—CYP2D6—Alzheimer's disease	6.01e-05	0.000383	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—CALM1—Alzheimer's disease	5.99e-05	0.000382	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—GSK3A—Alzheimer's disease	5.96e-05	0.00038	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—PLCB1—Alzheimer's disease	5.92e-05	0.000377	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—CCR5—Alzheimer's disease	5.87e-05	0.000374	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—APP—Alzheimer's disease	5.86e-05	0.000373	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—HTR2A—Alzheimer's disease	5.74e-05	0.000366	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—BCHE—Alzheimer's disease	5.69e-05	0.000363	CbGpPWpGaD
Guanabenz—ADRA2A—Platelet activation, signaling and aggregation—AKT1—Alzheimer's disease	5.64e-05	0.00036	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—F2—Alzheimer's disease	5.63e-05	0.000359	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—PRKCG—Alzheimer's disease	5.62e-05	0.000358	CbGpPWpGaD
Guanabenz—ADRA2C—Hemostasis—VEGFA—Alzheimer's disease	5.61e-05	0.000358	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—NPY—Alzheimer's disease	5.6e-05	0.000357	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—IAPP—Alzheimer's disease	5.57e-05	0.000354	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	5.56e-05	0.000354	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—PLCB1—Alzheimer's disease	5.53e-05	0.000352	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—PPARGC1A—Alzheimer's disease	5.53e-05	0.000352	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—NGFR—Alzheimer's disease	5.52e-05	0.000352	CbGpPWpGaD
Guanabenz—ADRA2B—Hemostasis—TGFB1—Alzheimer's disease	5.52e-05	0.000351	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—HMOX1—Alzheimer's disease	5.5e-05	0.00035	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—CREB1—Alzheimer's disease	5.49e-05	0.00035	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CRH—Alzheimer's disease	5.4e-05	0.000344	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—ADAM10—Alzheimer's disease	5.4e-05	0.000344	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—PLCB1—Alzheimer's disease	5.37e-05	0.000342	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—CCL2—Alzheimer's disease	5.37e-05	0.000342	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—CCR5—Alzheimer's disease	5.33e-05	0.000339	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—HTR2A—Alzheimer's disease	5.22e-05	0.000332	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—ABCA1—Alzheimer's disease	5.21e-05	0.000332	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—NGFR—Alzheimer's disease	5.16e-05	0.000329	CbGpPWpGaD
Guanabenz—ADRA2C—Hemostasis—TGFB1—Alzheimer's disease	5.15e-05	0.000328	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—CREB1—Alzheimer's disease	5.13e-05	0.000327	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—NPS—Alzheimer's disease	5.12e-05	0.000326	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—S100B—Alzheimer's disease	5.1e-05	0.000325	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PPP3CA—Alzheimer's disease	5.1e-05	0.000325	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	5.07e-05	0.000323	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—ADAM10—Alzheimer's disease	5.04e-05	0.000321	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—F2—Alzheimer's disease	5.04e-05	0.000321	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—LPL—Alzheimer's disease	5.03e-05	0.00032	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PTK2B—Alzheimer's disease	5.02e-05	0.00032	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—CCL2—Alzheimer's disease	5.02e-05	0.00032	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—NTRK2—Alzheimer's disease	4.89e-05	0.000311	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—SST—Alzheimer's disease	4.89e-05	0.000311	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—GAB2—Alzheimer's disease	4.89e-05	0.000311	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—CALM1—Alzheimer's disease	4.87e-05	0.00031	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—IGF2—Alzheimer's disease	4.86e-05	0.000309	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—GSK3A—Alzheimer's disease	4.84e-05	0.000308	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—S100B—Alzheimer's disease	4.77e-05	0.000304	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—APP—Alzheimer's disease	4.76e-05	0.000303	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—IGF1R—Alzheimer's disease	4.7e-05	0.000299	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—TPI1—Alzheimer's disease	4.65e-05	0.000296	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—CHAT—Alzheimer's disease	4.65e-05	0.000296	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—F2—Alzheimer's disease	4.57e-05	0.000291	CbGpPWpGaD
Guanabenz—ADRA2A—Hemostasis—VEGFA—Alzheimer's disease	4.56e-05	0.00029	CbGpPWpGaD
Guanabenz—ADRA2B—Hemostasis—TP53—Alzheimer's disease	4.54e-05	0.000289	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—IGF2—Alzheimer's disease	4.54e-05	0.000289	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—MTHFR—Alzheimer's disease	4.53e-05	0.000289	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—LPL—Alzheimer's disease	4.5e-05	0.000287	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PLCB1—Alzheimer's disease	4.49e-05	0.000286	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—PPARGC1A—Alzheimer's disease	4.49e-05	0.000286	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—HMOX1—Alzheimer's disease	4.47e-05	0.000285	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—MEF2C—Alzheimer's disease	4.46e-05	0.000284	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—MAOB—Alzheimer's disease	4.46e-05	0.000284	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—IGF1R—Alzheimer's disease	4.39e-05	0.000279	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—PRKCG—Alzheimer's disease	4.38e-05	0.000279	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—GAPDH—Alzheimer's disease	4.29e-05	0.000274	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—NGF—Alzheimer's disease	4.27e-05	0.000272	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	4.25e-05	0.00027	CbGpPWpGaD
Guanabenz—ADRA2C—Hemostasis—TP53—Alzheimer's disease	4.24e-05	0.00027	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—CALM1—Alzheimer's disease	4.23e-05	0.00027	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—APOE—Alzheimer's disease	4.22e-05	0.000269	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—LPL—Alzheimer's disease	4.21e-05	0.000268	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	4.21e-05	0.000268	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—NGFR—Alzheimer's disease	4.19e-05	0.000267	CbGpPWpGaD
Guanabenz—ADRA2A—Hemostasis—TGFB1—Alzheimer's disease	4.19e-05	0.000267	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—CAV1—Alzheimer's disease	4.18e-05	0.000266	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—MEF2C—Alzheimer's disease	4.17e-05	0.000266	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—CREB1—Alzheimer's disease	4.17e-05	0.000265	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—CCR5—Alzheimer's disease	4.15e-05	0.000264	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—A2M—Alzheimer's disease	4.15e-05	0.000264	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—ADAM10—Alzheimer's disease	4.09e-05	0.000261	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—PRKCG—Alzheimer's disease	4.09e-05	0.000261	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—LPL—Alzheimer's disease	4.09e-05	0.00026	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—CCL2—Alzheimer's disease	4.08e-05	0.00026	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—HTR2A—Alzheimer's disease	4.06e-05	0.000259	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—NGF—Alzheimer's disease	3.98e-05	0.000254	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—CCR5—Alzheimer's disease	3.88e-05	0.000247	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—S100B—Alzheimer's disease	3.87e-05	0.000247	CbGpPWpGaD
Guanabenz—ADRA2B—Hemostasis—AKT1—Alzheimer's disease	3.83e-05	0.000244	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—HTR2A—Alzheimer's disease	3.79e-05	0.000242	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—CALM1—Alzheimer's disease	3.79e-05	0.000241	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—LEP—Alzheimer's disease	3.78e-05	0.00024	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—APOE—Alzheimer's disease	3.78e-05	0.00024	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—CAV1—Alzheimer's disease	3.74e-05	0.000238	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	3.7e-05	0.000236	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—IGF2—Alzheimer's disease	3.69e-05	0.000235	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—MTHFR—Alzheimer's disease	3.68e-05	0.000234	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—PPARG—Alzheimer's disease	3.67e-05	0.000234	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—ACHE—Alzheimer's disease	3.61e-05	0.00023	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—ESR1—Alzheimer's disease	3.6e-05	0.00023	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—INS—Alzheimer's disease	3.6e-05	0.000229	CbGpPWpGaD
Guanabenz—ADRA2C—Hemostasis—AKT1—Alzheimer's disease	3.58e-05	0.000228	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—INPP5D—Alzheimer's disease	3.57e-05	0.000227	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—IGF1R—Alzheimer's disease	3.56e-05	0.000227	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—F2—Alzheimer's disease	3.56e-05	0.000227	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—CALM1—Alzheimer's disease	3.54e-05	0.000225	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—APOE—Alzheimer's disease	3.53e-05	0.000225	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—LEP—Alzheimer's disease	3.53e-05	0.000225	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—CAV1—Alzheimer's disease	3.49e-05	0.000223	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—NOTCH1—Alzheimer's disease	3.48e-05	0.000222	CbGpPWpGaD
Guanabenz—ADRA2A—Hemostasis—TP53—Alzheimer's disease	3.45e-05	0.000219	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—CALM1—Alzheimer's disease	3.44e-05	0.000219	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—APOE—Alzheimer's disease	3.43e-05	0.000218	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—LPL—Alzheimer's disease	3.42e-05	0.000218	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—CAV1—Alzheimer's disease	3.39e-05	0.000216	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—MEF2C—Alzheimer's disease	3.39e-05	0.000216	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—ENO1—Alzheimer's disease	3.38e-05	0.000215	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PTGS1—Alzheimer's disease	3.38e-05	0.000215	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—ESR1—Alzheimer's disease	3.37e-05	0.000214	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—F2—Alzheimer's disease	3.33e-05	0.000212	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PRKCG—Alzheimer's disease	3.32e-05	0.000212	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—CYP2D6—Alzheimer's disease	3.32e-05	0.000211	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—GSK3B—Alzheimer's disease	3.27e-05	0.000208	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—NOTCH1—Alzheimer's disease	3.25e-05	0.000207	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—CREB1—Alzheimer's disease	3.24e-05	0.000207	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—NGF—Alzheimer's disease	3.24e-05	0.000206	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—INS—Alzheimer's disease	3.23e-05	0.000205	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—CCL2—Alzheimer's disease	3.17e-05	0.000202	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—NOS3—Alzheimer's disease	3.16e-05	0.000201	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CCR5—Alzheimer's disease	3.15e-05	0.000201	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—BCHE—Alzheimer's disease	3.14e-05	0.0002	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—IGF1—Alzheimer's disease	3.12e-05	0.000199	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—HTR2A—Alzheimer's disease	3.08e-05	0.000196	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—GSK3B—Alzheimer's disease	3.05e-05	0.000195	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—CREB1—Alzheimer's disease	3.03e-05	0.000193	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—INS—Alzheimer's disease	3.01e-05	0.000192	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—PPARG—Alzheimer's disease	2.98e-05	0.00019	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PLCB1—Alzheimer's disease	2.97e-05	0.000189	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—CCL2—Alzheimer's disease	2.96e-05	0.000189	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—INS—Alzheimer's disease	2.93e-05	0.000186	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—IGF1—Alzheimer's disease	2.91e-05	0.000186	CbGpPWpGaD
Guanabenz—ADRA2A—Hemostasis—AKT1—Alzheimer's disease	2.91e-05	0.000185	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	2.91e-05	0.000185	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—PTGS2—Alzheimer's disease	2.89e-05	0.000184	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—ABCA1—Alzheimer's disease	2.87e-05	0.000183	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CALM1—Alzheimer's disease	2.87e-05	0.000183	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—LEP—Alzheimer's disease	2.86e-05	0.000182	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—APOE—Alzheimer's disease	2.86e-05	0.000182	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CAV1—Alzheimer's disease	2.84e-05	0.000181	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—NOS3—Alzheimer's disease	2.83e-05	0.00018	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—ESR1—Alzheimer's disease	2.73e-05	0.000174	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—F2—Alzheimer's disease	2.7e-05	0.000172	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—NOTCH1—Alzheimer's disease	2.64e-05	0.000168	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—NOS3—Alzheimer's disease	2.64e-05	0.000168	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—NOS3—Alzheimer's disease	2.57e-05	0.000163	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—GSK3B—Alzheimer's disease	2.48e-05	0.000158	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PPARGC1A—Alzheimer's disease	2.48e-05	0.000158	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—HMOX1—Alzheimer's disease	2.47e-05	0.000157	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CREB1—Alzheimer's disease	2.46e-05	0.000157	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—INS—Alzheimer's disease	2.45e-05	0.000156	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR downstream signaling—AKT1—Alzheimer's disease	2.42e-05	0.000154	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CCL2—Alzheimer's disease	2.41e-05	0.000153	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—CASP3—Alzheimer's disease	2.4e-05	0.000153	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—IL6—Alzheimer's disease	2.39e-05	0.000152	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—IGF1—Alzheimer's disease	2.37e-05	0.000151	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—PTGS2—Alzheimer's disease	2.35e-05	0.00015	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR downstream signaling—AKT1—Alzheimer's disease	2.26e-05	0.000144	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—LPL—Alzheimer's disease	2.26e-05	0.000144	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—CASP3—Alzheimer's disease	2.24e-05	0.000143	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—IL6—Alzheimer's disease	2.23e-05	0.000142	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—MAPK8—Alzheimer's disease	2.21e-05	0.000141	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—AKT1—Alzheimer's disease	2.2e-05	0.00014	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—NOS3—Alzheimer's disease	2.15e-05	0.000137	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—MAPK8—Alzheimer's disease	2.06e-05	0.000131	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—AKT1—Alzheimer's disease	2.06e-05	0.000131	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—VEGFA—Alzheimer's disease	2.04e-05	0.00013	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—MTHFR—Alzheimer's disease	2.03e-05	0.000129	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—VEGFA—Alzheimer's disease	1.9e-05	0.000121	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—CALM1—Alzheimer's disease	1.9e-05	0.000121	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—APOE—Alzheimer's disease	1.89e-05	0.00012	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—CAV1—Alzheimer's disease	1.87e-05	0.000119	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—TGFB1—Alzheimer's disease	1.87e-05	0.000119	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—AKT1—Alzheimer's disease	1.84e-05	0.000117	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CASP3—Alzheimer's disease	1.82e-05	0.000116	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—IL6—Alzheimer's disease	1.81e-05	0.000115	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—TGFB1—Alzheimer's disease	1.75e-05	0.000111	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—MAPK8—Alzheimer's disease	1.67e-05	0.000107	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—AKT1—Alzheimer's disease	1.67e-05	0.000106	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PPARG—Alzheimer's disease	1.65e-05	0.000105	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—INS—Alzheimer's disease	1.62e-05	0.000103	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—VEGFA—Alzheimer's disease	1.55e-05	9.85e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—TP53—Alzheimer's disease	1.54e-05	9.81e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—AKT1—Alzheimer's disease	1.45e-05	9.25e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—TP53—Alzheimer's disease	1.44e-05	9.16e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—TGFB1—Alzheimer's disease	1.42e-05	9.04e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—NOS3—Alzheimer's disease	1.42e-05	9.02e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—IL6—Alzheimer's disease	1.41e-05	8.98e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—IL6—Alzheimer's disease	1.32e-05	8.38e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—AKT1—Alzheimer's disease	1.3e-05	8.28e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PTGS2—Alzheimer's disease	1.3e-05	8.25e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—AKT1—Alzheimer's disease	1.21e-05	7.74e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—AKT1—Alzheimer's disease	1.18e-05	7.51e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—TP53—Alzheimer's disease	1.17e-05	7.44e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—IL6—Alzheimer's disease	1.07e-05	6.81e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—AKT1—Alzheimer's disease	9.86e-06	6.28e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—AKT1—Alzheimer's disease	6.51e-06	4.15e-05	CbGpPWpGaD
